Even if immune responses targeting citrullinated antigens are ultimately required to develop the combined lung-joint phenotype of RA-ILD, however, anti-MAA antibodies may be useful biomarkers in pre-RA as well as other lung diseases that include sarcoidosis and idiopathic bronchiectasis. The gene discussed is NAA10; the disease is idiopathic bronchiectasis.